反応式
C(OC(=O)[NH:7][C:8]([C:10]1[S:11][C:12]([S:26][CH3:27])=[C:13]([S:15]([C:18]2[CH:19]=[N:20][C:21](Cl)=[C:22]([Br:24])[CH:23]=2)(=[O:17])=[O:16])[CH:14]=1)=[NH:9])(C)(C)C.[NH2:29][C:30]1[C:35]([CH2:36][NH2:37])=[CH:34][N:33]=[C:32](C)[N:31]=1.C(Cl)Cl.[C:42]([OH:48])([C:44]([F:47])([F:46])[F:45])=[O:43]>C1COCC1>[F:45][C:44]([F:47])([F:46])[C:42]([OH:48])=[O:43].[NH2:29][C:30]1[C:35]([CH2:36][NH:37][C:21]2[N:20]=[CH:19][C:18]([S:15]([C:13]3[CH:14]=[C:10]([C:8]([NH2:9])=[NH:7])[S:11][C:12]=3[S:26][CH3:27])(=[O:16])=[O:17])=[CH:23][C:22]=2[Br:24])=[CH:34][N:33]=[CH:32][N:31]=1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
The reaction was conducted following the procedure for Example 164: step c, using {[4-(5-bromo-6-chloro-pyridine-3-sulfonyl)-5-methylsulfanyl-thiophen-2-yl]-imino-methyl}-carbamic acid tert-butyl ester (0.035 g, 0.067 mmol), 4-amino-5-aminomethyl-2-methylpyrimidine (0.018 g, 0.135 mmol), THF [2 mL], followed by DCM/TFA (1:1) and reverse-phase HPLC to yield the title compound. ESI-MS (m/z): Calcd. for C18H19BrN6O2S3: 528.48 (M+H); found 528.0, 529.9.
出典と根拠
- ORDレコード
- ord-7b4d4ea3689b47a69936d134fa6fc0ff
- 出典データセット
- uspto-grants-2006_09
- 特許番号
- US07109354B2
関連ノート
読み込み中…